Clinical Trials Logo

Clinical Trial Summary

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.


Clinical Trial Description

By enrolling patients with small metastases of kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03357289
Study type Interventional
Source Fuda Cancer Hospital, Guangzhou
Contact
Status Completed
Phase Phase 1/Phase 2
Start date November 30, 2017
Completion date August 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT03357276 - Mix Vaccine for Metastatic Colorectal Cancer Phase 1/Phase 2
Completed NCT03357315 - Mix Vaccine for Metastatic Sarcoma Patients Phase 1/Phase 2